Schizophrenia-Insights

Schizophrenia Conference Insights

Muscarinic Acetylcholine Receptors in Schizophrenia: A Shift From Dopamine D2 to Muscarinic Agonists

11/27/2024

Craig Chepke, MD, DFAPA

In this video, Craig Chepke, MD, DFAPA, scientific director, Psych Congress, explains the vital differences between dopamine D2 receptor antipsychotics and muscarinic agonists for the treatment of schizophrenia, including mechanisms of action...

In this video, Craig Chepke, MD,...

11/27/2024

Psych Congress Network

Schizophrenia Conference Insights

New Class of Medication Offers Innovative Treatment for Schizophrenia Symptoms

11/07/2024

Desiree Matthews, PHMNP-BC

Watch these exclusive insights with Desiree Matthews, PMHNP-BC, to learn how this novel treatment could reshape the landscape of care for adults living with schizophrenia.

Watch these exclusive insights...

11/07/2024

Psych Congress Network

Schizophrenia Insights

LAIs Are Not a Last Resort in Schizophrenia Treatment, Expert Says

09/27/2023

Veronica Ridpath, DO

Veronica Ridpath, DO, addresses clinician bias towards the use of long-acting injectables for schizophrenia treatment.

Veronica Ridpath, DO, addresses...

09/27/2023

Psych Congress Network

Schizophrenia Insights

LAIs Are Not a Last Resort in Schizophrenia Treatment, Expert Says

09/27/2023

Veronica Ridpath, DO

Veronica Ridpath, DO, addresses clinician bias towards the use of long-acting injectables for schizophrenia treatment.

Veronica Ridpath, DO, addresses...

09/27/2023

Psych Congress Network

Schizophrenia Insights

Why Early Identification is Key to Functional Recovery in Schizophrenia

09/14/2023

Christoph U. Correll, MD

Christoph Correll, MD, discusses why early intervention in schizophrenia is key to effective treatment and functional recovery.

Christoph Correll, MD, discusses...

09/14/2023

Psych Congress Network

Schizophrenia Insights

Why Early Identification is Key to Functional Recovery in Schizophrenia

09/14/2023

Christoph U. Correll, MD

Christoph Correll, MD, discusses why early intervention in schizophrenia is key to effective treatment and functional recovery.

Christoph Correll, MD, discusses...

09/14/2023

Psych Congress Network

Schizophrenia Insights

Addressing Agitation Through a Collaborative Conversation

11/14/2022

Section Editor Leslie Citrome, MD, MPH, discuss his clinical approach to handling patient agitation, including presenting patients with a range of medication administration options from oral to intramuscular injection.

Section Editor Leslie Citrome,...

11/14/2022

Psych Congress Network

Tracks

ADHD

MDD Insights

Schizophrenia-Insights

Major Depressive Disorder

General Psychiatry

About

Celebrating 35 years of empowering the highest standard in mental healthcare, Psych Congress serves as a unique, integrated forum to connect members of the entire mental health team—bringing together psychiatrists, nurse practitioners, physician assistants, psychologists, primary care physicians, and other mental health professionals for 4 days of practical education to improve patient care.